UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes

Nature communications, 2021-05, Vol.12 (1), p.2623-2623, Article 2623

2021

Link zum Volltext

Verfügbarkeit prüfen

Drug Intelligence Science (DIS®): Pioneering a high-resolution translational platform to enhance the probability of success for drug discovery and development

Drug discovery today, 2023-11, Vol.28 (11), p.103795-103795, Article 103795

Schweizer, Liang

2023

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression

Molecular cancer therapeutics, 2015-10, Vol.14 (10), p.2167-2174

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeting epigenetic regulators for cancer therapy

Annals of the New York Academy of Sciences, 2014-02, Vol.1309 (1), p.30-36

2014

Link zum Volltext

Verfügbarkeit prüfen

Casein Kinase Iε Modulates the Signaling Specificities of Dishevelled

Molecular and Cellular Biology, 2004-03, Vol.24 (5), p.2000-2011

2004

Link zum Volltext

Verfügbarkeit prüfen

Global or local: The future of biotech

Drug discovery today, 2023-05, Vol.28 (5), p.103528-103528, Article 103528

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study

Frontiers in pharmacology, 2023-05, Vol.14, p.1117293-1117293

2023

Link zum Volltext

Verfügbarkeit prüfen

Guiding principles of value creation through collaborative innovation in pharmaceutical research

Drug discovery today, 2018-02, Vol.23 (2), p.213-218

2018

Link zum Volltext

Verfügbarkeit prüfen

A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses

PloS one, 2016-06, Vol.11 (6), p.e0155909-e0155909

2016

Link zum Volltext

Verfügbarkeit prüfen

Requirement for a Nuclear Function of β-Catenin in Wnt Signaling

Molecular and Cellular Biology, 2003-12, Vol.23 (23), p.8462-8470

2003

Link zum Volltext

Verfügbarkeit prüfen

SDRS—an algorithm for analyzing large-scale dose–response data

Bioinformatics, 2011-10, Vol.27 (20), p.2921-2923

2011

Link zum Volltext

Verfügbarkeit prüfen

Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy

Cancer Growth and Metastasis, 2013-01, Vol.2013 (2013), p.53-59

2013

Link zum Volltext

Verfügbarkeit prüfen

Requirement for Pangolin/dTCF in Drosophila Wingless Signaling

Proceedings of the National Academy of Sciences - PNAS, 2003-05, Vol.100 (10), p.5846-5851

2003

Link zum Volltext

Verfügbarkeit prüfen

Drosophila coracle, a member of the protein 4.1 superfamily, has essential structural functions in the septate junctions and developmental functions in embryonic and adult epithelial cells

Molecular biology of the cell, 1998-12, Vol.9 (12), p.3505-3519

1998

Link zum Volltext

Verfügbarkeit prüfen

Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP

Development (Cambridge), 2004-10, Vol.131 (20), p.5103-5115

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6532: HFB9-2: A novel Gal-9 neutralizing antibody to reverse immune suppression in the tumor microenvironment

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6532-6532

2020

Link zum Volltext

Verfügbarkeit prüfen

High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics

Science advances, 2021-06, Vol.7 (24)

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PO-048: Combined single-T cell clonotyping and phenotyping defines a predictive response signature that identifies patients more likely to respond to therapy

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (21_Supplement), p.PO-048-PO-048

2020

Link zum Volltext

Verfügbarkeit prüfen

Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)

Bioorganic & medicinal chemistry letters, 2024-01, Vol.98, p.129589-129589, Article 129589

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1843: Dicovery and characterization of a novel anti-human CXCR5 antibody for the treatment of B cell lymphomas

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1843-1843

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2282: Discovery and characterization of novel TNFR2 antibodies to modulate T cell activities in immunosuppressive environment

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2282-2282

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1883: Mechanism of action and biomarker strategy for HFB200301, an anti-TNFR2 agonist antibody for the treatment of cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1883-1883

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1884: HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancers

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1884-1884

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1882: Clinical approach and biomarker strategy for HFB301001, a novel OX40 agonistic antibody

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1882-1882

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2285: HFB10-1E1, a novel OX-40 agonistic antibody with a unique pharmacological profile and biomarker strategy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2285-2285

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(27)
Humans
(15)
Animals
(11)
Cell Biology
(8)
Pharmacology & Pharmacy
(8)
Physical Sciences
(8)
Chemistry
(7)
Multidisciplinary Sciences
(7)
Science & Technology - Other Topics
(7)
Cytoskeletal Proteins - Metabolism
(6)
Beta Catenin
(5)
Biochemistry & Molecular Biology
(5)
Biological And Medical Sciences
(5)
Cell Line, Tumor
(5)
Drosophila
(5)
Drosophila - Genetics
(5)
Male
(5)
Oncology
(5)
Proto-Oncogene Proteins - Metabolism
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes

Drug Intelligence Science (DIS®): Pioneering a high-resolution translational platform to enhance the probability of success for drug discovery and development

Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression

Targeting epigenetic regulators for cancer therapy

Casein Kinase Iε Modulates the Signaling Specificities of Dishevelled

Global or local: The future of biotech

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study

Guiding principles of value creation through collaborative innovation in pharmaceutical research

A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses

Requirement for a Nuclear Function of β-Catenin in Wnt Signaling

SDRS—an algorithm for analyzing large-scale dose–response data

Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy

Requirement for Pangolin/dTCF in Drosophila Wingless Signaling

Drosophila coracle, a member of the protein 4.1 superfamily, has essential structural functions in the septate junctions and developmental functions in embryonic and adult epithelial cells

Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP

Abstract 6532: HFB9-2: A novel Gal-9 neutralizing antibody to reverse immune suppression in the tumor microenvironment

High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics

Abstract PO-048: Combined single-T cell clonotyping and phenotyping defines a predictive response signature that identifies patients more likely to respond to therapy

Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)

Abstract 1843: Dicovery and characterization of a novel anti-human CXCR5 antibody for the treatment of B cell lymphomas

Abstract 2282: Discovery and characterization of novel TNFR2 antibodies to modulate T cell activities in immunosuppressive environment

Abstract 1883: Mechanism of action and biomarker strategy for HFB200301, an anti-TNFR2 agonist antibody for the treatment of cancer

Abstract 1884: HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancers

Abstract 1882: Clinical approach and biomarker strategy for HFB301001, a novel OX40 agonistic antibody

Abstract 2285: HFB10-1E1, a novel OX-40 agonistic antibody with a unique pharmacological profile and biomarker strategy

Suchergebnisse filtern